Research programme: neuropsychological disorders therapeutics - Herophilus
Latest Information Update: 03 Mar 2023
At a glance
- Originator Herophilus
- Class Antipsychotics; Neuropsychotherapeutics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research DiGeorge syndrome; Schizophrenia
Most Recent Events
- 01 Feb 2023 Early research in DiGeorge syndrome in USA (unspecified route) (Herophilus pipeline; February 2023)
- 01 Feb 2023 Early research in Schizophrenia in USA (unspecified route) (Herophilus pipeline; February 2023)